Tobacco use is associated with poor outcomes (e.g., increased toxicity) in cancer patients, and tobacco cessation is related to several favorable outcomes (e.g., improved response to cancer treatments, decreased risk for a second primary tumor, increased survival). However, tobacco cessation support is not routinely provided to cancer patients. This presentation will cover the current status of tobacco assessment and cessation in clinical practice and in clinical trials. Specifically, national data regarding cancer treatment provider behaviors and preferences with regard to tobacco assessment and cessation support will be discussed. In addition, tobacco use assessment and referral or provision of treatment in national clinical trials will be reviewed. Strategies for implementation of tobacco cessation into standard clinical cancer care will be discussed, with a presentation of a variety of prototypical programs. The ongoing need for additional research in all of these areas will also be discussed.
Citation Format: Benjamin A. Toll. Tobacco assessment and cessation in cancer patients: An urgent need. [abstract]. In: Proceedings of the Twelfth Annual AACR International Conference on Frontiers in Cancer Prevention Research; 2013 Oct 27-30; National Harbor, MD. Philadelphia (PA): AACR; Can Prev Res 2013;6(11 Suppl): Abstract nr PL01-03.